Immune-Mediated Necrotizing Myopathy Manifesting after Five Years of Statin Therapy
Immune-mediated necrotizing myopathy (IMNM) is an increasingly common and serious condition in which autoantibodies attack muscle fibers causing clinically significant muscle weakness, fatigue, and myalgias. Recognizing the clinical presentation of IMNM is difficult but necessary, as rapid intervent...
Saved in:
Main Authors: | Nathan G. DeRon, Francis Fischer, Dylan Lopez, Elizabeth C. Brewer |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Case Reports in Rheumatology |
Online Access: | http://dx.doi.org/10.1155/2023/1178035 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Challenges in Treating Statin-Associated Necrotizing Myopathy
by: Patrick Webster, et al.
Published: (2021-01-01) -
When Should a Patient with Statin-Induced Myopathy Be Re-challenged? A Case of Necrotizing Autoimmune Myopathy
by: Elena Obreja, et al.
Published: (2018-01-01) -
Complete Recovery from COVID-19 Bilateral Pneumonia in an Immunosuppressed Man with Immune-Mediated Necrotizing Myopathy
by: Thomas C. Bolig, et al.
Published: (2020-01-01) -
Identification of clinical subgroups in anti-SRP positive immune-mediated necrotizing myopathy patients using cluster analysis
by: Beibei Cui, et al.
Published: (2025-01-01) -
Anti-3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Immune-Mediated Necrotizing Myopathy following mRNA SARS-CoV-2 Vaccination
by: Marta Rodrigues de Carvalho, et al.
Published: (2023-01-01)